{"name":"Shanghai Runshi Pharmaceutical Technology Co., Ltd","slug":"shanghai-runshi-pharmaceutical-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Paclitaxel or docetaxel or irinotecan","genericName":"Paclitaxel or docetaxel or irinotecan","slug":"paclitaxel-or-docetaxel-or-irinotecan","indication":"Non-small cell lung cancer","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"simmitinib","genericName":"simmitinib","slug":"simmitinib","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Paclitaxel or docetaxel or irinotecan","genericName":"Paclitaxel or docetaxel or irinotecan","slug":"paclitaxel-or-docetaxel-or-irinotecan","phase":"phase_3","mechanism":"These taxane and camptothecin chemotherapy agents stabilize microtubules or inhibit topoisomerase I to disrupt cell division and induce apoptosis in cancer cells.","indications":["Non-small cell lung cancer","Breast cancer","Ovarian cancer","Gastric cancer","Colorectal cancer"],"catalyst":""},{"name":"simmitinib","genericName":"simmitinib","slug":"simmitinib","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}